We are live on
!
Find out more
PC
Pier Capital Portfolio holdings
AUM
$755M
Turnover
32.67%
1-Year Est. Return
94.38%
This Fund
S&P 500
This Quarter
Est. Return
+8.16%
1 Year Est. Return
+94.38%
3 Year Est. Return
+222.94%
5 Year Est. Return
+261.19%
10 Year Est. Return
+2,769.67%
AUM
$997M
AUM Growth
-$57.5M
(-5.5%)
Cap. Flow
-$122M
Cap. Flow
% of AUM
-12.22%
Top 10 Holdings %
Top 10 Hldgs %
13.92%
Holding
125
New
8
Increased
27
Reduced
74
Closed
9
Avg Time Held
1.4
years
Top 10 Avg Time Held
0.1
years
Top 20 Avg Time Held
0.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Everbridge, Inc. Common Stock
EVBG
|
+$12M |
| 2 |
Jamf
JAMF
|
+$11M |
| 3 |
RadNet
RDNT
|
+$8.57M |
| 4 |
POSH
Poshmark, Inc. Class A Common Stock
POSH
|
+$7.35M |
| 5 |
Lindblad Expeditions
LIND
|
+$6.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Methode Electronics
MEI
|
+$12.7M |
| 2 |
Redfin
RDFN
|
+$12.7M |
| 3 |
Diodes
DIOD
|
+$12.3M |
| 4 |
CoreCard
CCRD
|
+$12M |
| 5 |
Q2 Holdings
QTWO
|
+$9.26M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.69% |
| 2 | Healthcare | 22.32% |
| 3 | Industrials | 14.98% |
| 4 | Consumer Discretionary | 13.37% |
| 5 | Financials | 6.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
POSH
76
DELISTED
Poshmark, Inc. Class A Common Stock
POSH
| $8.18M | 0.82% |
+171,301
| New | +$7.35M |
2021 Q2
0 quarters
|
|
77
Adaptive Biotechnologies
ADPT
$3.83B
| $8.16M | 0.82% |
199,697
+42,736
| +27% | +$1.66M |
2020 Q2
4 quarters
|
|
78
Omnicell
OMCL
$1.61B
| $7.99M | 0.8% |
52,726
-33,103
| -39% | -$4.61M |
2017 Q3
15 quarters
|
|
79
Personalis
PSNL
$1.67B
| $7.86M | 0.79% |
310,616
+5,357
| +2% | +$123K |
2020 Q4
2 quarters
|
|
80
Workiva
WK
$4.1B
| $7.83M | 0.79% |
70,340
-10,027
| -12% | -$974K |
2019 Q4
6 quarters
|
|
81
Ollie's Bargain Outlet
OLLI
$5.54B
| $7.62M | 0.76% |
90,627
+18,891
| +26% | +$1.64M |
2016 Q4
18 quarters
|
|
82
SiteOne Landscape Supply
SITE
$4.14B
| $7.34M | 0.74% |
43,355
-5,833
| -12% | -$1.02M |
2016 Q2
20 quarters
|
|
83
Allogene Therapeutics
ALLO
$453M
| $7.27M | 0.73% |
278,828
+5,182
| +2% | +$148K |
2020 Q3
3 quarters
|
|
84
DELISTED
Acutus Medical Inc
AFIB
| $7.25M | 0.73% |
427,049
-55,434
| -11% | -$811K |
2021 Q1
1 quarter
|
|
85
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $7.16M | 0.72% |
76,708
+25,802
| +51% | +$2.5M |
2020 Q4
2 quarters
|
|
86
Alector
ALEC
$205M
| $7.02M | 0.7% |
336,914
-168,489
| -33% | -$3.18M |
2021 Q1
1 quarter
|
|
|
MYOV
87
DELISTED
Myovant Sciences Ltd.
MYOV
| $6.84M | 0.69% |
300,616
-254,163
| -46% | -$5.35M |
2020 Q3
3 quarters
|
|
88
Vital Farms
VITL
$361M
| $6.73M | 0.67% |
336,967
+91,577
| +37% | +$2.03M |
2020 Q3
3 quarters
|
|
89
Schrodinger
SDGR
$1.69B
| $6.51M | 0.65% |
86,172
-11,943
| -12% | -$866K |
2020 Q1
5 quarters
|
|
90
DELISTED
BioLife Solutions
BLFS
| $6.46M | 0.65% |
145,145
-17,703
| -11% | -$624K |
2020 Q4
2 quarters
|
|
91
DoubleVerify
DV
$2.11B
| $6M | 0.6% |
+141,774
| New | +$5.05M |
2021 Q2
0 quarters
|
|
92
Tandem Diabetes Care
TNDM
$1.13B
| $6M | 0.6% |
61,613
-9,417
| -13% | -$840K |
2019 Q2
8 quarters
|
|
93
DELISTED
Revance Therapeutics, Inc.
RVNC
| $5.05M | 0.51% |
+170,316
| New | +$4.91M |
2021 Q2
0 quarters
|
|
94
Repligen
RGEN
$11.1B
| $5.04M | 0.51% |
25,232
-25,424
| -50% | -$4.93M |
2016 Q4
18 quarters
|
|
95
LGI Homes
LGIH
$1,000M
| $4.92M | 0.49% |
30,412
-25,921
| -46% | -$4.29M |
2019 Q1
9 quarters
|
|
96
Insulet
PODD
$9.79B
| $1.41M | 0.14% |
5,126
+1,852
| +57% | +$503K |
2018 Q3
11 quarters
|
|
97
CRISPR Therapeutics
CRSP
$4.76B
| $1.03M | 0.1% |
+6,374
| New | +$775K |
2021 Q2
0 quarters
|
|
|
COUP
98
DELISTED
Coupa Software Incorporated
COUP
| $942K | 0.09% |
3,594
+1,402
| +64% | +$347K |
2018 Q2
12 quarters
|
|
99
Pinterest
PINS
$12.4B
| $846K | 0.08% |
10,718
-5,273
| -33% | -$368K |
2019 Q2
8 quarters
|
|
100
WIX.com
WIX
$3.14B
| $804K | 0.08% |
2,771
-450
| -14% | -$126K |
2020 Q4
2 quarters
|
|
Similar funds
HFS
FFA
KCG
SCM
PCM
AFAS
ACM
M
Pier Capital's Q2 2021 Portfolio in Review
As of Q2 2021, Pier Capital held 125 positions worth $997M, down 5.5% from $1.05B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Pier Capital withdrew a net $122M in Q2 2021, closing 9 positions and reducing 74 holdings. Its most notable exit was Methode Electronics, an estimated $12.7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 30% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Pier Capital opened a new position in Everbridge, Inc. Common Stock worth $13M.
- Pier Capital's largest Q2 2021 buy was Everbridge, Inc. Common Stock: 95,651 shares worth $13M.
- Pier Capital added most to Lindblad Expeditions in Q2 2021, an estimated $6.1M increase.
- Pier Capital's biggest Q2 2021 reduction was Progyny, cutting an estimated $6.68M.
- Pier Capital fully exited Methode Electronics in Q2 2021, selling an estimated $12.7M.
- Pier Capital's ten largest holdings make up 14% of its $997M portfolio in Q2 2021.
- Pier Capital opened 8 new positions and closed 9 in Q2 2021.
- Pier Capital's portfolio value fell 5.5% quarter-over-quarter to $997M.
Based on Pier Capital's 13F filing for Q2 2021, filed 12 Aug 2021.